Integrating On-Treatment Modified Glasgow Prognostic Score and Imaging to Predict Response and Outcomes in Metastatic Renal Cell Carcinoma

IMPORTANCE: In the era of immuno-oncology, imaging alone seems to be insufficient to capture treatment responses, as patients with stable disease treated with immunotherapy have a wide range of clinical outcomes. There is an unmet need for complementary (ideally cost-efficient) markers that enable a...

Descripción completa

Detalles Bibliográficos
Autores principales: Saal, Jonas, Bald, Tobias, Eckstein, Markus, Ralser, Damian J., Ritter, Manuel, Brossart, Peter, Grünwald, Viktor, Hölzel, Michael, Ellinger, Jörg, Klümper, Niklas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Medical Association 2023
Materias:
Original Investigation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10288377/
https://www.ncbi.nlm.nih.gov/pubmed/37347489
http://dx.doi.org/10.1001/jamaoncol.2023.1822

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10288377/
https://www.ncbi.nlm.nih.gov/pubmed/37347489
http://dx.doi.org/10.1001/jamaoncol.2023.1822

Ejemplares similares